scispace - formally typeset
C

Carles Lerin

Researcher at Boston Children's Hospital

Publications -  31
Citations -  8713

Carles Lerin is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 21 publications receiving 8087 citations. Previous affiliations of Carles Lerin include Johns Hopkins University School of Medicine & University of Barcelona.

Papers
More filters
Journal ArticleDOI

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

TL;DR: RSV's effects were associated with an induction of genes for oxidative phosphorylation and mitochondrial biogenesis and were largely explained by an RSV-mediated decrease in P GC-1alpha acetylation and an increase in PGC-1 alpha activity.
Journal ArticleDOI

GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α

TL;DR: The endogenous P GC-1alpha protein complex is identified and the molecular mechanism by which PGC-1 alpha acetylation by GCN5 turns off the transcriptional and biological function of this metabolic coactivator is provided.
Journal ArticleDOI

eRah: A Computational Tool Integrating Spectral Deconvolution and Alignment with Quantification and Identification of Metabolites in GC/MS-Based Metabolomics

TL;DR: The automated capabilities of eRah are demonstrated by the analysis of GC-time-of-flight (TOF) MS data from plasma samples of adolescents with hyperinsulinaemic androgen excess and healthy controls, and the quantitative results are compared to centWave, the peak-picking algorithm implemented in the widely used XCMS package, MetAlign, and ChromaTOF software.
Journal ArticleDOI

Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.

TL;DR: The T1D patients presented a blunted metabolic response to acute exercise as compared to controls, and this attenuated response may interfere in the healthy performance or fitness of T2D patients, something that further studies should elucidate.